Stock listing

NASDAQ:SNTS Santarus Inc Stock

Follow Santarus Inc into a list and get an email when it puts out news.

Last close · NASDAQ:SNTS

$31.96 USD

Close on Dec 31, 2013 · No longer trades

Apr 1, 2004 to last close +216.4% · weekly closes, Apr 1, 2004 – Dec 31, 2013
Lowest – highest close
$1.18 – $32.18 USDSince Apr 1, 2004 · lowest Mar 16, 2009 · highest Nov 29, 2013

Delisted NASDAQ:SNTS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SNTS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Santarus Inc on 6ix

Decks
8 decks · latest Jul 9, 2013

Decks

DeckKindSlidesDate
Investor Presentation (July 2013)Investor deck32 slidesJul 9, 2013
Investor Day (April 2013)Investor day114 slidesApr 11, 2013
Investor Presentation (June 2011)Investor deck28 slidesJun 22, 2011
Technical Presentation (May 2011)Technical24 slidesMay 9, 2011
Technical Presentation (May 2011)Technical25 slidesMay 9, 2011
Investor Day (January 2011)Investor day108 slidesJan 20, 2011
Investor Presentation (January 2006)Investor deck28 slidesJan 6, 2006
Investor Presentation (September 2005)Investor deck27 slidesSep 27, 2005

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Wendall Wierenga
Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Cytokinetics, Incorporated (Director · Since at least Feb 9, 2011); Concert Pharmaceuticals Inc (Director · Mar 13, 2014 – Jun 14, 2018 · Past); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); XenoPort Inc (Director · May 7, 2009 – Jul 5, 2016 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past)
EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past
David Hale
Other companies: Dermata Therapeutics, Inc. (Lead Director · Since at least Aug 12, 2021); Oncternal Therapeutics Inc (Director · Jun 7, 2019 – Jun 20, 2024 · Past); Histogen Inc (Director · Jul 24, 2013 – Jun 27, 2019 · Past); Somaxon Pharmaceuticals Inc (Director · Apr 2, 2012 – Dec 31, 2012 · Past)
Director · Mar 21, 2012 – Jan 2, 2014 · Past
Michael E Herman
Other companies: Senomyx Inc (Director · May 31, 2007 – May 11, 2017 · Past); Cerner Corp (Director · May 25, 2007 – May 27, 2010 · Past)
Director · Jun 14, 2007 – Jan 2, 2014 · Past
Maria E Bedoya-Toro
Other companies: Dermata Therapeutics, Inc. (SVP, Regulatory Affairs · Since at least Aug 12, 2021)
SVP, Regulatory Affairs & QA · May 28, 2007 – Jan 2, 2014 · Past
Julie A De MeulesSr. VP, Human Resources · Feb 9, 2006 – Jan 2, 2014 · Past
Mark TotoritisSVP, Clinical Research · Mar 12, 2012 – Jan 2, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about Santarus Inc.